Metalcaptase® 300 mg

Active substance:


ATC-Code :


Pharmaceutical form:

enteric coated tablet

Therapeutic indications:

  • Morbus Wilson
  • Lead, Mercury, copper, and zinc poisoning
  • Rheumatoid arthritis
  • Cystinuria with detected cysteine stones when recurrence of stones cannot be prevented by other methods ( diet, hyperhydration, alkalisation of urine) as well as in cases of advanced cysteine stone disorders involving special risks (e.g. after nephrectomy).